Showing 11–16 of 16
bills
All healthcare bills
SB 253 prevents Louisiana's professional licensing boards from banning healthcare providers with prescriptive authority from prescribing peptides shipped from FDA-registered 503B facilities or FDA-registered compounding pharmacies. It directly affects doctors and other licensed prescribers who currently use such peptide sources. The bill requires providers to verify that prescribed peptides are not on the FDA's prohibited compounding list. This law aims to remove regulatory barriers for access to specific peptide treatments while ensuring compliance with federal FDA guidelines.
SB 206 requires all Louisiana public school districts to conduct blood pressure screenings for students during the first semester or within 30 days of enrollment, following the American Academy of Pediatrics' recommended schedule. School boards must document results, follow up on abnormal readings within 60 days, and notify parents in writing if issues are found. This applies to public schools but exempts charter schools from the blood pressure screening requirement specifically (while they still follow other health screening rules). The bill aims to identify hypertension early in students through standardized school-based testing.
HB 926, the "Louisiana Medical Freedom Act," prohibits public buildings, government services, and businesses from denying access or services based on an individual's vaccine status or refusal of any medical intervention (including vaccines). It bans government entities from requiring vaccinations for public building access, employment, or services, and prevents businesses from denying services or employment based on medical intervention refusal. The bill explicitly states that healthy individuals cannot be excluded from public activities during health emergencies due to declining a vaccine. This law applies broadly to all public facilities, government services, and businesses operating in Louisiana.
HB 452 prohibits health insurance plans from offering extra payments to healthcare providers to encourage administering vaccinations or denying reimbursement/charging penalties to influence vaccination rates. It directly affects insurance companies and healthcare providers by banning financial incentives or penalties tied to vaccine administration. The law applies to most health insurance plans (including employer-sponsored and HMO plans) but excludes limited benefit plans and short-term policies. This creates a clear policy change: insurers cannot use financial pressure to steer providers toward or away from vaccinating patients.
HB 742 removes a requirement that applicants for the Family Independence Temporary Assistance Program and Medicaid must have certain immunizations. The bill repeals specific sections of Louisiana law (R.S. 46:231.4 and Section 13 of Act No. 478) that previously mandated these vaccinations for program eligibility. It directs the Department of Children and Family Services and the Louisiana Department of Health to update their rules to align with this change. This policy change directly affects individuals applying for these two public assistance programs by eliminating a vaccination prerequisite.
SB 4 changes Louisiana's water fluoridation policy by ending the state mandate for fluoridation in public water systems. Instead, it requires local voter approval via election for any system to fluoridate, with exceptions for systems already meeting natural fluoride levels. This directly affects public water systems serving over 5,000 connections that currently fluoridate or need to adjust fluoride levels. The bill takes effect January 1, 2027, replacing the previous requirement with a local decision process.